AGM Statement
27/06/2022 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220627:nRSa1815Qa&default-theme=true
RNS Number : 1815Q Medica Group PLC 27 June 2022
27 June 2022
Medica Group Plc
AGM Statement
Medica Group PLC (LSE:MGP, "Medica" or the "Company"), the UK and Ireland
market leader in the provision of teleradiology services, is holding its
Annual General Meeting ("AGM") at 11.00am today at the offices of DLA Piper,
160 Aldersgate Street, London EC1A 4HT.
No new information will be presented at the meeting. The Company plans to
issue an update on trading for the six months ended 30 June 2022 on 26 July
2022.
For further information, please contact:
Medica Group Plc: +44 (0)33 33 111 222
Stuart Quin, Chief Executive Officer
Richard Jones, Chief Financial Officer
FTI Consulting +44 (0)20 3727 1000
Victoria Foster Mitchell
Sam Purewal
Liberum (Joint Broker) +44 (0)20 3100 2000
Phil Walker
Richard Lindley
Numis (Joint Broker) +44 (0)20 7260 1000
Freddie Barnfield
Duncan Monteith
Euan Brown
About Medica Group PLC
Medica is the market leader in the UK and Ireland for the provision of
teleradiology services, providing outsourced interpretation and reporting of
MRI (magnetic resonance imaging), CT (computerised tomography), ultrasound and
plain film (x-ray) images. Medica also offers diabetic retinopathy screening
in Ireland.
Medica contracts with the largest pool of consultant radiologists in the UK
and Ireland, performing remote access teleradiology across its customer base
of more than 100 NHS Trusts in the UK, the Irish HSE, private hospital and
insurance groups, as well as diagnostic imaging companies. This enables the
Company to offer a fast, responsive service. In addition, Medica operates in
Australia and New Zealand through MedX, a 50:50 Joint Venture with Integral
Diagnostics Limited Pty.
The Company currently offers two primary services to hospital radiology
departments:
· NightHawk - urgent reporting service
· Elective - includes routine cross-sectional reporting on MRI and
CT scans, and routine plain film reporting on x-ray images.
These services are underpinned by Medica's bespoke, secure IT platform that
provides market-leading linkage between a hospital's Radiology Information
System (RIS) and consultant radiologists who contract with the Company. Direct
RIS access ensures that where the wider patient medical history is available,
it can be reviewed by the consultant as part of every report.
Through its subsidiary, RadMD, in the United States, Medica also provides
pharmaceutical and biotech clients and contract research organisations (CROs)
with high quality, complex imaging services for international clinical trials.
RadMD has gained vast experience in the space, having contributed to over 500
international clinical trials, in all phases of clinical research from proof
of concept to phase III and with expertise in oncology, as well as a wider
range of therapeutic areas including medical devices, neurology and
cardiovascular.
For more information please visit: www.medicagroupplc.com
(http://www.medicagroupplc.com/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NOAEALKLALNAEFA